Zullo Investment Group Inc. trimmed its stake in shares of The Clorox Company (NYSE:CLX – Free Report) by 8.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,043 shares of the company’s stock after selling 263 shares during the quarter. Zullo Investment Group Inc.’s holdings in Clorox were worth $494,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors also recently modified their holdings of the company. Insight Folios Inc raised its holdings in Clorox by 3.0% during the 3rd quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock worth $358,000 after buying an additional 63 shares during the period. HCR Wealth Advisors lifted its position in shares of Clorox by 1.0% in the fourth quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock worth $1,116,000 after purchasing an additional 68 shares in the last quarter. Empower Advisory Group LLC grew its position in Clorox by 4.5% in the third quarter. Empower Advisory Group LLC now owns 1,823 shares of the company’s stock valued at $297,000 after purchasing an additional 78 shares in the last quarter. Aviance Capital Partners LLC increased its stake in Clorox by 2.7% in the 3rd quarter. Aviance Capital Partners LLC now owns 3,080 shares of the company’s stock valued at $502,000 after buying an additional 80 shares during the last quarter. Finally, Lindbrook Capital LLC lifted its position in Clorox by 9.9% during the 3rd quarter. Lindbrook Capital LLC now owns 977 shares of the company’s stock worth $159,000 after buying an additional 88 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of analysts recently issued reports on the company. Evercore ISI lifted their target price on Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Barclays raised their price target on Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a report on Wednesday, February 5th. Wells Fargo & Company boosted their price target on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 4th. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and lifted their price target for the company from $155.00 to $170.00 in a research report on Wednesday, November 6th. Finally, JPMorgan Chase & Co. lifted their price target on Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research note on Tuesday, February 4th. Four equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, Clorox currently has a consensus rating of “Hold” and a consensus target price of $158.21.
Clorox Trading Up 1.8 %
NYSE CLX opened at $150.93 on Thursday. The stock has a 50 day simple moving average of $158.38 and a two-hundred day simple moving average of $159.74. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The stock has a market cap of $18.68 billion, a P/E ratio of 41.24, a price-to-earnings-growth ratio of 2.53 and a beta of 0.42.
Clorox (NYSE:CLX – Get Free Report) last issued its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the prior year, the company posted $2.16 earnings per share. On average, analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.
Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading
- Five stocks we like better than Clorox
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- What is a Special Dividend?
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- The 3 Best Retail Stocks to Shop for in August
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.